93 related articles for article (PubMed ID: 38061006)
21. Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients With Advanced Prostate Cancer From Latin America: Challenges and Future Approaches.
Manneh R; Verson CA; Martin A; Delgado A; Isaacsson Velho PH; Manduley A; Tejado L; Rodríguez Y; Vargas C; Barata PC
JCO Precis Oncol; 2024 May; 8():e2300628. PubMed ID: 38748947
[TBL] [Abstract][Full Text] [Related]
22. Prediction of homologous recombination deficiency from Oncomine Comprehensive Assay Plus correlating with SOPHiA DDM HRD Solution.
Kang J; Na K; Kang H; Cho U; Kwon SY; Hwang S; Lee A
PLoS One; 2024; 19(3):e0298128. PubMed ID: 38527014
[TBL] [Abstract][Full Text] [Related]
23. Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.
Hwang J; Shi X; Elliott A; Arnoff TE; McGrath J; Xiu J; Walker P; Bergom HE; Day A; Ahmed S; Tape S; Makovec A; Ali A; Shaker RM; Toye E; Passow R; Lozada JR; Wang J; Lou E; Mouw KW; Carneiro BA; Heath EI; McKay RR; Korn WM; Nabhan C; Ryan CJ; Antonarakis ES
Clin Cancer Res; 2023 Jul; 29(14):2702-2713. PubMed ID: 37126020
[TBL] [Abstract][Full Text] [Related]
24. Determining homologous recombination deficiency scores with whole exome sequencing and their association with responses to neoadjuvant chemotherapy in breast cancer.
Kim SJ; Sota Y; Naoi Y; Honma K; Kagara N; Miyake T; Shimoda M; Tanei T; Seno S; Matsuda H; Noguchi S; Shimazu K
Transl Oncol; 2021 Feb; 14(2):100986. PubMed ID: 33340887
[TBL] [Abstract][Full Text] [Related]
25. Using whole-genome sequencing data to derive the homologous recombination deficiency scores.
de Luca XM; Newell F; Kazakoff SH; Hartel G; McCart Reed AE; Holmes O; Xu Q; Wood S; Leonard C; Pearson JV; Lakhani SR; Waddell N; Nones K; Simpson PT
NPJ Breast Cancer; 2020; 6():33. PubMed ID: 32818150
[TBL] [Abstract][Full Text] [Related]
26. PARP inhibitors in prostate cancers, is it time for combinations?
Teyssonneau D; Dariane C; Barret E; Beauval JB; Brureau L; Fiard G; Fromont G; Créhange G; Gauthé M; Ruffion A; Renard-Penna R; Mathieu R; Sargos P; Rouprêt M; Ploussard G; Roubaud G
Ther Adv Med Oncol; 2024; 16():17588359241242959. PubMed ID: 38827177
[TBL] [Abstract][Full Text] [Related]
27. A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency.
Kohsaka S; Yagishita S; Shirai Y; Matsuno Y; Ueno T; Kojima S; Ikeuchi H; Ikegami M; Kitada R; Yoshioka KI; Toshimitsu K; Tabata K; Yokoi A; Doi T; Yamamoto N; Owa T; Hamada A; Mano H
NPJ Precis Oncol; 2024 May; 8(1):117. PubMed ID: 38789724
[TBL] [Abstract][Full Text] [Related]
28. A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures.
Diossy M; Sztupinszki Z; Borcsok J; Krzystanek M; Tisza V; Spisak S; Rusz O; Timar J; Csabai I; Fillinger J; Moldvay J; Pedersen AG; Szuts D; Szallasi Z
NPJ Precis Oncol; 2021 Jun; 5(1):55. PubMed ID: 34145376
[TBL] [Abstract][Full Text] [Related]
29. Genetic testing for homologous recombination repair (HRR) in metastatic castration-resistant prostate cancer (mCRPC): challenges and solutions.
Scott RJ; Mehta A; Macedo GS; Borisov PS; Kanesvaran R; El Metnawy W
Oncotarget; 2021 Aug; 12(16):1600-1614. PubMed ID: 34381565
[TBL] [Abstract][Full Text] [Related]
30. Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate Cancer.
Schostak M; Bradbury A; Briganti A; Gonzalez D; Gomella L; Mateo J; Penault-Llorca F; Stenzinger A; Wyatt AW; Bjartell A
Eur Urol Oncol; 2024 Jun; 7(3):344-354. PubMed ID: 37714762
[TBL] [Abstract][Full Text] [Related]
31. Harmonization of homologous recombination deficiency testing in ovarian cancer: Results from the MITO16A/MaNGO-OV2 trial.
Roma C; Esposito Abate R; Sacco A; Califano D; Arenare L; Bergantino F; Pisano C; Cecere SC; Scambia G; Lorusso D; Artioli G; Tasca G; Spina A; Russo D; Gadducci A; De Angelis C; Bologna A; Marchini S; Capoluongo ED; Perrone F; Pignata S; Normanno N
Eur J Cancer; 2024 May; 206():114127. PubMed ID: 38797038
[TBL] [Abstract][Full Text] [Related]
32. Is it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?
Teo MY; O'Reilly EM
J Gastrointest Oncol; 2016 Oct; 7(5):738-749. PubMed ID: 27747088
[TBL] [Abstract][Full Text] [Related]
33. Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes.
Rosenbaum E; Jonsson P; Seier K; Qin LX; Chi P; Dickson M; Gounder M; Kelly C; Keohan ML; Nacev B; Donoghue MTA; Chiang S; Singer S; Ladanyi M; Antonescu CR; Hensley ML; Movva S; D'Angelo SP; Tap WD
JCO Precis Oncol; 2020; 4():. PubMed ID: 33283135
[TBL] [Abstract][Full Text] [Related]
34. Screening and Testing for Homologous Recombination Repair Deficiency (HRD) in Breast Cancer: an Overview of the Current Global Landscape.
Daly GR; Naidoo S; Alabdulrahman M; McGrath J; Dowling GP; AlRawashdeh MM; Hill ADK; Varešlija D; Young L
Curr Oncol Rep; 2024 Jun; ():. PubMed ID: 38822929
[TBL] [Abstract][Full Text] [Related]
35. LC3B drives transcription-associated homologous recombination via direct interaction with R-loops.
Yoon J; Hwang Y; Yun H; Chung JM; Kim S; Kim G; Lee Y; Lee BD; Kang HC
Nucleic Acids Res; 2024 May; 52(9):5088-5106. PubMed ID: 38412240
[TBL] [Abstract][Full Text] [Related]
36. Race-Specific Genetic Profiles of Homologous Recombination Deficiency in Multiple Cancers.
Hsiao YW; Lu TP
J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945758
[TBL] [Abstract][Full Text] [Related]
37. Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in Tumor.
Ball M; Ourailidis I; Kluck K; Menzel M; Kirchner M; Allgäuer M; Tay TKY; Schnecko F; Volckmar AL; Goldschmid H; Neuman O; Fröhling S; Schirmacher P; Budczies J; Stenzinger A; Kazdal D
J Mol Diagn; 2024 Jun; 26(6):479-486. PubMed ID: 38522840
[TBL] [Abstract][Full Text] [Related]
38. Challenges of diagnosing homologous recombination deficiencies in metastatic prostate cancer: a six-year experience from a single institution.
Gavira J; Tapia JC; Romano A; Anguera G; Aguado M; Piedra A; Bosma F; Sánchez S; Martin C; Algaba F; Arce Y; Ramón Y Cajal T; Maroto P
Clin Transl Oncol; 2024 May; ():. PubMed ID: 38722534
[TBL] [Abstract][Full Text] [Related]
39. The genomic landscape of breast- and non-breast cancers from individuals with germline CHEK2-deficiency.
Hinić S; van der Post RS; Vreede L; Schuurs-Hoeijmakers J; Koene S; Jansen EAM; Bervoets-Metge F; Mensenkamp AR; Hoogerbrugge N; Ligtenberg MJL; de Voer RM
JNCI Cancer Spectr; 2024 Jun; ():. PubMed ID: 38848470
[TBL] [Abstract][Full Text] [Related]
40. Homologous recombination repair capacity in peripheral blood lymphocytes and breast cancer risk.
Shen J; Song R; Chow WH; Zhao H
Carcinogenesis; 2020 Oct; 41(10):1363-1367. PubMed ID: 32692853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
